# FDA Inspection 963313 - HQ Specialty Pharma - January 15, 2016

Source: https://www.globalkeysolutions.net/records/fda_inspections/hq-specialty-pharma/11377318-0d4f-4275-8e43-a40e841bd239
Source feed: FDA_Inspections

> FDA Inspection 963313 for HQ Specialty Pharma on January 15, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 963313
- Company Name: HQ Specialty Pharma
- Inspection Date: 2016-01-15
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1067103 - 2018-09-07](https://www.globalkeysolutions.net/records/fda_inspections/hq-specialty-pharma/e90d7a53-6945-41af-b710-68d379ca4b57)

Company: https://www.globalkeysolutions.net/companies/hq-specialty-pharma/3933b8ff-d302-48bc-b051-22aa866ab131

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c